speb/financial-data huggingface dataset:
Financial ratios for LEDS — quarterly report dated 2025-08-31
Total revenue: 433748.77008855366
Gross profit: 7510.659232535258
Operating income: -32338.471630042637
Net income: -39160.38045260742
Capital expenditures: 688.7504099704821
Operating cash flow: 8920.957691046246
Depreciation & amortization: 6723.515906854706
Net tangible assets: 87897.67136766153
Owner earnings: -33125.61495572319
Return on net tangible assets (%): -37.68656716417911
Buffett classification: The Gruesome
Stock price: 1.87
Shares outstanding: 8273403
Book value: 91177.43522466382
P/B ratio: 169.6830314636331
Market cap (USD): 15471263.610000001
Debt to equity: 1.0248201438848923
Current ratio: 0.9928841254502327
Quick ratio: 0.5733110779232188
Interest coverage ratio: -89.63636363636364
COGS to revenue (%): 98.26843100189035
R&D to revenue (%): 2.7372400756143667
SG&A to revenue (%): 6.449905482041587
Free cash flow (dilution-adjusted): 7805.837979665464
Buyback yield (%): 0
Retained earnings: -6225352.574614628
Inventory turnover: 2.7211055276381906
Receivables turnover: 3.6858974358974357
Capitalized R&D asset: 21225.32925810572
ROCI (R&D-adjusted, %): -19.15263984439828
Rosenberg metric: -2.447968568180899
FCF margin (%): 1.7996219281663517
Revenue growth (%): -26.64777753587147
Rule of 40 score: -24.848155607705117
Financial ratios for LEDS — quarterly report dated 2025-11-30
Total revenue: 82050.46311082722
Gross profit: 574.8961992973491
Operating income: -33248.163526030025
Net income: -23698.49888214628
Capital expenditures: 0
Operating cash flow: 11529.862663685724
Depreciation & amortization: 5780.900670712233
Net tangible assets: 62599.80836793357
Owner earnings: -17917.598211434048
Return on net tangible assets (%): -28.622448979591837
Buffett classification: The Gruesome
Stock price: 2.02
Shares outstanding: 8273403
Book value: 66081.12424145645
P/B ratio: 252.90541363876252
Market cap (USD): 16712274.06
Debt to equity: 1.2788786853552432
Current ratio: 0.9385362279014383
Quick ratio: 0.579188421727581
Interest coverage ratio: -86.75
COGS to revenue (%): 99.29933826391593
R&D to revenue (%): 13.857532113662904
SG&A to revenue (%): 27.364733359283772
Free cash flow (dilution-adjusted): 9294.155221973811
Buyback yield (%): 0
Retained earnings: -6086010.859150431
Inventory turnover: 0.650267652306908
Receivables turnover: 1.3760042849491163
Capitalized R&D asset: 22553.049237282972
ROCI (R&D-adjusted, %): -25.6128793477996
Rosenberg metric: -0.5841751792359774
FCF margin (%): 11.327364733359286
Revenue growth (%): -81.08341307940174
Rule of 40 score: -69.75604834604245
Financial ratios for LNT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.99
Shares outstanding: 258277037
Market cap (USD): 13686100190.630001
Buyback yield (%): 1.4613366643108987
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LNT — annual report dated 2022-12-31
Total revenue: 4205000000
Gross profit: 1709000000
Operating income: 928000000
Net income: 686000000
Capital expenditures: 372000000
Operating cash flow: 486000000
Depreciation & amortization: 671000000
Net tangible assets: 6276000000
Owner earnings: 985000000
Return on net tangible assets (%): 15.694710006373485
Capex to operating income (%): 40.08620689655172
Buffett classification: The Good
Stock price: 49.05
P/E ratio: 18.467184642638482
Shares outstanding: 258277037
Book value: 6276000000
P/B ratio: 2.0185609727294453
Market cap (USD): 12668488664.849998
Debt to equity: 1.3891013384321225
Current ratio: 0.5289885738468049
Quick ratio: 0.3914515446466356
Effective tax rate (%): 3.1073446327683616
Interest coverage ratio: 2.855384615384615
COGS to revenue (%): 59.357907253269914
Free cash flow (dilution-adjusted): 486000000
Buyback yield (%): 0
Retained earnings: 3509000000
Inventory turnover: 7.68
Receivables turnover: 12.70392749244713
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.213483146067416
FCF margin (%): 11.557669441141497
Rule of 40 score: 11.557669441141497
Financial ratios for LNT — annual report dated 2023-12-31
Total revenue: 4027000000
Gross profit: 1734000000
Operating income: 943000000
Net income: 703000000
Capital expenditures: 712000000
Operating cash flow: 867000000
Depreciation & amortization: 676000000
Net tangible assets: 6777000000
Owner earnings: 667000000
Return on net tangible assets (%): 9.842113029364025
Capex to operating income (%): 75.50371155885472
Buffett classification: The Gruesome
Stock price: 47.17
P/E ratio: 17.32991157224751
Shares outstanding: 258277037
Book value: 6777000000
P/B ratio: 1.7976874480286262
Market cap (USD): 12182927835.29
Debt to equity: 1.403128227829423
Current ratio: 0.5520833333333334
Quick ratio: 0.4032118055555556
Effective tax rate (%): 0.5657708628005658
Interest coverage ratio: 2.5625
COGS to revenue (%): 56.94065060839334
Free cash flow (dilution-adjusted): 867000000
Buyback yield (%): 0
Retained earnings: 3756000000
Inventory turnover: 6.685131195335277
Receivables turnover: 15.548262548262548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.980721491575555
FCF margin (%): 21.529674695803326
Revenue growth (%): -4.233055885850178
Rule of 40 score: 17.29661880995315
Financial ratios for LNT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 57.39
Shares outstanding: 258277037
Market cap (USD): 14822519153.43
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LNT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.38
Shares outstanding: 258277037
Market cap (USD): 14561659346.060001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LNT — annual report dated 2024-12-31
Total revenue: 3981000000
Gross profit: 1780000000
Operating income: 886000000
Net income: 690000000
Capital expenditures: 1224000000
Operating cash flow: 1167000000
Depreciation & amortization: 772000000
Net tangible assets: 7004000000
Owner earnings: 238000000
Return on net tangible assets (%): 3.3980582524271843
Capex to operating income (%): 138.14898419864562
Buffett classification: The Gruesome
Stock price: 56.38
P/E ratio: 21.10385412472464
Shares outstanding: 258277037
Book value: 7004000000
P/B ratio: 2.0790490214249
Market cap (USD): 14561659346.060001
Debt to equity: 1.4857224443175328
Current ratio: 0.43609576427255986
Quick ratio: 0.3274401473296501
Effective tax rate (%): -19.791666666666664
Interest coverage ratio: 2.0700934579439254
COGS to revenue (%): 55.28761617683999
Free cash flow (dilution-adjusted): 1167000000
Buyback yield (%): 0
Retained earnings: 3954000000
Inventory turnover: 7.461016949152542
Receivables turnover: 15.079545454545455
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.430221511075554
FCF margin (%): 29.314242652599848
Revenue growth (%): -1.1422895455674198
Rule of 40 score: 28.17195310703243
Financial ratios for LNT — quarterly report dated 2025-03-31
Total revenue: 1128000000
Gross profit: 498000000
Operating income: 257000000
Net income: 213000000
Capital expenditures: 0
Operating cash flow: 249000000
Depreciation & amortization: 211000000
Net tangible assets: 7093000000
Owner earnings: 424000000
Return on net tangible assets (%): 5.977724517129564
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 61.88
P/E ratio: 18.758430809342723
Shares outstanding: 258277037
Book value: 7093000000
P/B ratio: 2.2532331946369664
Market cap (USD): 15982183049.560001
Debt to equity: 1.4985196672775976
Current ratio: 0.3355263157894737
Quick ratio: 0.24376731301939059
Effective tax rate (%): -28.313253012048197
Interest coverage ratio: 2.1596638655462184
COGS to revenue (%): 55.85106382978723
Free cash flow (dilution-adjusted): 249000000
Buyback yield (%): 0
Retained earnings: 4037000000
Inventory turnover: 2.3773584905660377
Receivables turnover: 3.1246537396121883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.287381656063718
FCF margin (%): 22.074468085106382
Rule of 40 score: 22.074468085106382
Financial ratios for LNT — quarterly report dated 2025-06-30
Total revenue: 961000000
Gross profit: 462000000
Operating income: 223000000
Net income: 174000000
Capital expenditures: 0
Operating cash flow: 243000000
Depreciation & amortization: 209000000
Net tangible assets: 7145000000
Owner earnings: 383000000
Return on net tangible assets (%): 5.36039188243527
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 58.63
P/E ratio: 39.12863741423773
Shares outstanding: 258277037
Book value: 7145000000
P/B ratio: 2.1193537689727084
Market cap (USD): 15142782679.310001
Debt to equity: 1.5825052484254725
Current ratio: 0.5715393563396666
Quick ratio: 0.46374563784412565
Effective tax rate (%): -32.82442748091603
Interest coverage ratio: 1.7983870967741935
COGS to revenue (%): 51.925078043704474
Free cash flow (dilution-adjusted): 243000000
Buyback yield (%): 0
Retained earnings: 4080000000
Inventory turnover: 1.7949640287769784
Receivables turnover: 1.8552123552123552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0533276652023995
FCF margin (%): 25.286160249739854
Revenue growth (%): -14.804964539007093
Rule of 40 score: 10.481195710732761
Financial ratios for LNT — quarterly report dated 2025-09-30
Total revenue: 1210000000
Gross profit: 589000000
Operating income: 349000000
Net income: 281000000
Capital expenditures: 0
Operating cash flow: 408000000
Depreciation & amortization: 211000000
Net tangible assets: 7307000000
Owner earnings: 492000000
Return on net tangible assets (%): 6.733269467633776
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 65.87
P/E ratio: 25.468126388008987
Shares outstanding: 258277037
Book value: 7307000000
P/B ratio: 2.3282754108649244
Market cap (USD): 17012708427.19
Debt to equity: 1.631449295196387
Current ratio: 0.8254252461951657
Quick ratio: 0.6996418979409131
Effective tax rate (%): -6.844106463878327
Interest coverage ratio: 2.7265625
COGS to revenue (%): 51.32231404958678
Free cash flow (dilution-adjusted): 408000000
Buyback yield (%): 0
Retained earnings: 4231000000
Inventory turnover: 2.209964412811388
Receivables turnover: 2.4948453608247423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5585227526459162
FCF margin (%): 33.71900826446281
Revenue growth (%): 25.910509885535898
Rule of 40 score: 59.6295181499987
Financial ratios for LNT — annual report dated 2025-12-31
Total revenue: 4362000000
Gross profit: 1992000000
Operating income: 1025000000
Net income: 810000000
Capital expenditures: 0
Operating cash flow: 1169000000
Depreciation & amortization: 846000000
Net tangible assets: 7334000000
Owner earnings: 1656000000
Return on net tangible assets (%): 22.57976547586583
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 64.01
P/E ratio: 20.410263133790124
Shares outstanding: 258277037
Book value: 7334000000
P/B ratio: 2.2542014096495775
Market cap (USD): 16532313138.37
Debt to equity: 1.6520316334878646
Current ratio: 0.7993405558172397
Quick ratio: 0.6636834667922751
Effective tax rate (%): -22.54160363086233
Interest coverage ratio: 2.1090534979423867
COGS to revenue (%): 54.33287482806052
Free cash flow (dilution-adjusted): 1169000000
Buyback yield (%): 0
Retained earnings: 4243000000
Inventory turnover: 8.229166666666666
Receivables turnover: 12.462857142857143
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.482245933181739
FCF margin (%): 26.79963319578175
Revenue growth (%): 9.570459683496608
Rule of 40 score: 36.37009287927836
Financial ratios for LNT — quarterly report dated 2025-12-31
Total revenue: 1064000000
Gross profit: 442000000
Operating income: 197000000
Net income: 142000000
Capital expenditures: 0
Operating cash flow: 269000000
Depreciation & amortization: 215000000
Net tangible assets: 7334000000
Owner earnings: 357000000
Return on net tangible assets (%): 4.867739296427597
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 64.01
P/E ratio: 20.410263133790124
Shares outstanding: 258277037
Book value: 7334000000
P/B ratio: 2.2542014096495775
Market cap (USD): 16532313138.37
Debt to equity: 1.6520316334878646
Current ratio: 0.7993405558172397
Quick ratio: 0.6636834667922751
Effective tax rate (%): -39.21568627450981
Interest coverage ratio: 1.7280701754385965
COGS to revenue (%): 58.45864661654135
Free cash flow (dilution-adjusted): 269000000
Buyback yield (%): 0
Retained earnings: 4243000000
Inventory turnover: 2.1597222222222223
Receivables turnover: 3.04
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8614658037432219
FCF margin (%): 25.281954887218046
Revenue growth (%): -12.066115702479339
Rule of 40 score: 13.215839184738707
Financial ratios for LVIDE.AS — annual report dated 2021-12-31
Capital expenditures: 0
Operating cash flow: -67045.45454545454
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.6590909090909091
Shares outstanding: 5724655
Market cap (USD): 3773068.068181818
Free cash flow (dilution-adjusted): -67045.45454545454
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LVIDE.AS — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -31914.89361702128
Operating income: -225531.91489361704
Net income: -229787.2340425532
Capital expenditures: 0
Net tangible assets: -111702.12765957447
Owner earnings: -229787.2340425532
Buffett classification: The Gruesome
Stock price: 0.46808510638297873
Shares outstanding: 5724655
Book value: -111702.12765957447
Market cap (USD): 2679625.744680851
Debt to equity: -0.6666666666666666
Current ratio: 0
Quick ratio: 0
Interest coverage ratio: -53
Buyback yield (%): 0
Retained earnings: -229787.2340425532
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LVIDE.AS — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -147777.77777777778
Operating income: -224335.55555555556
Net income: -242873.3333333333
Capital expenditures: 0
Operating cash flow: -165356.66666666666
Net tangible assets: -359932.2222222222
Owner earnings: -242873.3333333333
Buffett classification: The Gruesome
Stock price: 0.2333333333333333
Shares outstanding: 5724655
Book value: -359932.2222222222
Market cap (USD): 1335752.8333333333
Debt to equity: -0.6772417029132028
Current ratio: 0.007995712754555198
Quick ratio: 0.007995712754555198
Interest coverage ratio: -15.058323389021481
Free cash flow (dilution-adjusted): -165356.66666666666
Buyback yield (%): 0
Retained earnings: -242873.3333333333
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LVIDE.AS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -156237.5
Buffett classification: The Gruesome
Stock price: 0.24175824175824176
Shares outstanding: 5724655
Book value: -156237.50000000006
Market cap (USD): 1383982.5274725275
Debt to equity: -2.9335680187748343
Current ratio: 0.7333764705464085
Quick ratio: 0.7333764705464085
Buyback yield (%): 0
Retained earnings: -339634.375
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LVIDE.AS — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -310617.7083333334
Net income: -339634.375
Capital expenditures: 0
Operating cash flow: -322359.375
Depreciation & amortization: 0
Net tangible assets: -156237.5
Owner earnings: -339634.375
Buffett classification: The Gruesome
Stock price: 0.24175824175824176
Shares outstanding: 5724655
Book value: -156237.50000000006
Market cap (USD): 1383982.5274725275
Debt to equity: -2.9335680187748343
Current ratio: 0.7333764705464085
Quick ratio: 0.7333764705464085
Interest coverage ratio: -14.33689119669215
Free cash flow (dilution-adjusted): -322359.375
Buyback yield (%): 0
Retained earnings: -339634.375
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LVIDE.AS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 144549.41176470587
Buffett classification: The Gruesome
Stock price: 0.24175824175824176
Shares outstanding: 5724655
Book value: 144549.4117647059
P/B ratio: 9.574459768299446
Market cap (USD): 1383982.5274725275
Debt to equity: 3.581108027379198
Current ratio: 1.2059000439293077
Quick ratio: 1.2059000439293077
Buyback yield (%): 0
Retained earnings: -852523.5294117647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLG.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6917293233082706
Shares outstanding: 160337151
Market cap (USD): 110909908.96240601
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLG.AX — annual report dated 2022-06-30
Total revenue: 197821171.72413793
Gross profit: 197118133.79310346
Operating income: 4336715.172413793
Net income: 3320503.4482758623
Capital expenditures: 7554957.931034483
Depreciation & amortization: 14689857.931034483
Net tangible assets: 80236441.37931035
Owner earnings: 10455403.448275864
Return on net tangible assets (%): 13.03074172849829
Capex to operating income (%): 174.20922589272635
Buffett classification: The Gruesome
Stock price: 0.30344827586206896
P/E ratio: 14.652606987307697
Shares outstanding: 160337151
Book value: 83023882.06896551
P/B ratio: 0.586024536737161
Market cap (USD): 48654032.02758621
Debt to equity: 0.5692871803426001
Current ratio: 0.8438810881126564
Quick ratio: 0.6174408478469863
Effective tax rate (%): 17.962570091411692
Interest coverage ratio: 12.94240763342753
COGS to revenue (%): 0.3553906414096418
SG&A to revenue (%): 39.748984156533524
Free cash flow (dilution-adjusted): 14867375.172413794
Buyback yield (%): 0.28994442863939646
Retained earnings: 47682353.79310345
Inventory turnover: 0.0561284859203204
Receivables turnover: 6.3359028680448946
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5232666290768613
FCF margin (%): 7.515563194189539
Rule of 40 score: 7.515563194189539
Financial ratios for MLG.AX — annual report dated 2023-06-30
Total revenue: 248483174.17218542
Gross profit: 248377330.46357617
Operating income: 2326348.344370861
Net income: 536201.9867549669
Capital expenditures: 234786.0927152318
Depreciation & amortization: 15478599.337748345
Net tangible assets: 78223117.8807947
Owner earnings: 15780015.23178808
Return on net tangible assets (%): 20.173083941547134
Capex to operating income (%): 10.092473609266262
Buffett classification: The Great
Stock price: 0.40397350993377484
P/E ratio: 120.79769053867957
Shares outstanding: 160337151
Book value: 78223811.25827816
P/B ratio: 0.8280338252554404
Market cap (USD): 64771961.66225166
Debt to equity: 0.5154929324673796
Current ratio: 0.7845151075894041
Quick ratio: 0.6006216547978912
Effective tax rate (%): 40.2236707368303
Interest coverage ratio: 4.929132908070913
COGS to revenue (%): 0.04259592584563796
SG&A to revenue (%): 42.20682278771054
Free cash flow (dilution-adjusted): 9560100
Buyback yield (%): 0
Retained earnings: 46323892.71523179
Inventory turnover: 0.010984000817009973
Receivables turnover: 8.898770089550833
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.103105996635388
FCF margin (%): 3.847383241078274
Revenue growth (%): 25.61000018678272
Rule of 40 score: 29.457383427860993
Financial ratios for MLG.AX — annual report dated 2024-06-30
Total revenue: 312412124
Gross profit: 313076202.6666667
Operating income: 11236161.333333334
Net income: 7305742
Capital expenditures: 12488228
Depreciation & amortization: 22792332
Net tangible assets: 87221935.33333333
Owner earnings: 17609846
Return on net tangible assets (%): 20.189698764079246
Capex to operating income (%): 111.14318875924529
Buffett classification: The Gruesome
Stock price: 0.5133333333333333
P/E ratio: 11.26598833903524
Shares outstanding: 160337151
Book value: 87221935.33333334
P/B ratio: 0.9436434065060834
Market cap (USD): 82306404.17999999
Debt to equity: 0.5177653284969148
Current ratio: 0.9330986837128952
Quick ratio: 0.7443902228535139
Effective tax rate (%): 32.76636631433665
Interest coverage ratio: 19.258447302839137
COGS to revenue (%): -0.21256494727671538
SG&A to revenue (%): 42.3733992688026
Free cash flow (dilution-adjusted): 25196707.333333332
Buyback yield (%): 0
Retained earnings: 53938460.666666664
Inventory turnover: -0.053593765308528746
Receivables turnover: 7.756323227045485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.646784607922429
FCF margin (%): 8.065214310739533
Revenue growth (%): 25.727677554342275
Rule of 40 score: 33.792891865081806
Financial ratios for NEXM — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 34
Shares outstanding: 35648164
Market cap (USD): 1212037576
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEXM — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -70987.5
Operating income: -11650067.647058822
Net income: -26772403.676470585
Capital expenditures: 21809857.352941174
Operating cash flow: -4057519.1176470583
Depreciation & amortization: 70987.5
Net tangible assets: 19991429.411764704
Owner earnings: -48511273.52941176
Return on net tangible assets (%): -242.66035474613682
Buffett classification: The Gruesome
Stock price: 23.94
Shares outstanding: 35648164
Book value: 19991429.411764704
P/B ratio: 42.68914586256523
Market cap (USD): 853417046.1600001
Debt to equity: 0.3665908081786813
Current ratio: 0.5166228387340709
Quick ratio: 0.5166228387340709
Interest coverage ratio: -31.027910073633088
Free cash flow (dilution-adjusted): -31771138.970588233
Buyback yield (%): 0
Retained earnings: -57421033.08823529
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -54.27057705757217
Rule of 40 score: 0
Financial ratios for NEXM — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -564229.5454545454
Operating income: -22767990.151515152
Net income: -24527325
Capital expenditures: 3614455.3030303027
Operating cash flow: -22320348.484848484
Depreciation & amortization: 564229.5454545454
Net tangible assets: 7383095.454545454
Owner earnings: -27577550.757575758
Return on net tangible assets (%): -373.5228797644414
Buffett classification: The Gruesome
Stock price: 18.66
Shares outstanding: 35648164
Book value: 7383095.454545457
P/B ratio: 90.09699851983736
Market cap (USD): 665194740.24
Debt to equity: 2.0320467948587706
Current ratio: 3.510059173807294
Quick ratio: 3.510059173807294
Interest coverage ratio: -11.64897844800688
Free cash flow (dilution-adjusted): -27037273.48484848
Buyback yield (%): 0
Retained earnings: -79217284.84848484
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -93.67523513137023
Rule of 40 score: 0
Financial ratios for NEXM — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 262652.5925925926
Buffett classification: The Gruesome
Stock price: 12.04
Shares outstanding: 35648164
Market cap (USD): 429203894.55999994
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEXM — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -344606.29370629374
Operating income: -7898007.692307693
Net income: -7884581.118881119
Capital expenditures: 696780.4195804197
Operating cash flow: -6888232.167832168
Depreciation & amortization: 344606.29370629374
Net tangible assets: -2410531.4685314684
Owner earnings: -8236755.244755245
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 35648164
Book value: -2410531.4685314707
Market cap (USD): 213888984
Debt to equity: -5.578478181406759
Current ratio: 1.810525237579297
Quick ratio: 1.810525237579297
Interest coverage ratio: -14.757615868079602
Free cash flow (dilution-adjusted): -7851035.664335664
Buyback yield (%): 0
Retained earnings: -102788181.11888112
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -54.440883120158404
Rule of 40 score: 0
Financial ratios for NEXM — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -1105783.216783217
Operating income: -27317903.4965035
Net income: -29664533.566433568
Capital expenditures: 714846.8531468532
Operating cash flow: -26293310.48951049
Depreciation & amortization: 1105783.216783217
Net tangible assets: -2410531.4685314684
Owner earnings: -29273597.202797204
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 35648164
Book value: -2410531.4685314707
Market cap (USD): 213888984
Debt to equity: -5.578478181406759
Current ratio: 1.810525237579297
Quick ratio: 1.810525237579297
Interest coverage ratio: -12.563716363615313
Free cash flow (dilution-adjusted): -29089042.657342657
Buyback yield (%): 0
Retained earnings: -102788181.11888112
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -188.30201859506803
Rule of 40 score: 0
Financial ratios for NEXM — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -444634.9650349651
Operating income: -6042926.573426574
Net income: -10649181.818181818
Capital expenditures: 34988.11188811189
Operating cash flow: -4402072.7272727275
Depreciation & amortization: 444634.9650349651
Net tangible assets: 36074026.573426574
Owner earnings: -10239534.965034965
Return on net tangible assets (%): -28.384785225439114
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 35648164
Book value: 36074026.573426574
P/B ratio: 5.929168554684114
Market cap (USD): 213888984
Debt to equity: 0.004195994956602254
Current ratio: 6.430378739316607
Quick ratio: 6.430378739316607
Interest coverage ratio: -20.172665750015756
Free cash flow (dilution-adjusted): -5155648.951048951
Buyback yield (%): 0
Retained earnings: -113437362.93706295
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.289180162425042
Rule of 40 score: 0
Financial ratios for NEXM — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -314833.57664233574
Operating income: -10850805.10948905
Net income: -11013683.21167883
Capital expenditures: 1065764.2335766423
Operating cash flow: -11234048.905109487
Depreciation & amortization: 314833.57664233574
Net tangible assets: 26682939.41605839
Owner earnings: -11764613.868613137
Return on net tangible assets (%): -44.09039680813025
Buffett classification: The Gruesome
Stock price: 9.4
Shares outstanding: 35648164
Book value: 26682939.41605839
P/B ratio: 12.558314373653065
Market cap (USD): 335092741.6
Debt to equity: 0.009375054625653117
Current ratio: 5.344106564192699
Quick ratio: 5.344106564192699
Free cash flow (dilution-adjusted): -12977610.948905108
Buyback yield (%): 0
Retained earnings: -129419105.83941604
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.77087155916943
Rule of 40 score: 0
Financial ratios for NEXM — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -355626.618705036
Operating income: -10794623.741007196
Net income: -11514005.755395684
Capital expenditures: 123007.19424460432
Operating cash flow: -9655489.208633095
Depreciation & amortization: 355626.618705036
Net tangible assets: 15564916.546762591
Owner earnings: -11281386.330935253
Return on net tangible assets (%): -72.47958122384995
Buffett classification: The Gruesome
Stock price: 5.52
Shares outstanding: 35648164
Book value: 15564916.546762591
P/B ratio: 12.642397708256818
Market cap (USD): 196777865.27999997
Debt to equity: 0.07842087587312437
Current ratio: 2.526652483687456
Quick ratio: 2.526652483687456
Free cash flow (dilution-adjusted): -10279510.071942447
Buyback yield (%): 0
Retained earnings: -139070966.18705037
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -54.54949494773227
Rule of 40 score: 0
Financial ratios for NEXM — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -1510088.321167883
Operating income: -37111027.00729927
Net income: -43128704.37956204
Capital expenditures: 2034075.912408759
Operating cash flow: -34730344.525547445
Depreciation & amortization: 1510088.321167883
Net tangible assets: 60547291.97080292
Owner earnings: -43652691.97080292
Return on net tangible assets (%): -72.09685280698118
Buffett classification: The Gruesome
Stock price: 3.91
Shares outstanding: 35648164
Book value: 60547291.97080292
P/B ratio: 2.302073580883086
Market cap (USD): 139384321.24
Debt to equity: 0.01952478722369279
Current ratio: 4.6672433997304426
Quick ratio: 4.6672433997304426
Interest coverage ratio: -118.6870889952868
Free cash flow (dilution-adjusted): -39275955.47445255
Buyback yield (%): 0
Retained earnings: -150418557.66423357
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -57.409289375282846
Rule of 40 score: 0
Financial ratios for NEXM — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -370328.46715328464
Operating income: -9000432.11678832
Net income: -9317358.394160584
Capital expenditures: 806988.3211678831
Operating cash flow: -9104986.131386861
Depreciation & amortization: 370328.46715328464
Net tangible assets: 60547291.97080292
Owner earnings: -9754018.248175181
Return on net tangible assets (%): -16.10975145325865
Buffett classification: The Gruesome
Stock price: 3.91
Shares outstanding: 35648164
Book value: 60547291.97080292
P/B ratio: 2.302073580883086
Market cap (USD): 139384321.24
Debt to equity: 0.01952478722369279
Current ratio: 4.6672433997304426
Quick ratio: 4.6672433997304426
Free cash flow (dilution-adjusted): -10487324.817518247
Buyback yield (%): 0
Retained earnings: -150418557.66423357
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.923312114042552
Rule of 40 score: 0
Financial ratios for NFBK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.26
Shares outstanding: 41763852
Market cap (USD): 553788677.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NFBK — annual report dated 2022-12-31
Total revenue: 166289000
Net income: 61119000
Capital expenditures: 2427000
Operating cash flow: 83331000
Depreciation & amortization: 8445000
Net tangible assets: 660378000
Owner earnings: 67137000
Return on net tangible assets (%): 10.16645012401988
Buffett classification: The Gruesome
Stock price: 13.38
P/E ratio: 9.14282530407893
Shares outstanding: 41763852
Book value: 701390000
P/B ratio: 0.7967041727997263
Market cap (USD): 558800339.76
Debt to equity: 0.940482470522819
Effective tax rate (%): 27.975818711038308
COGS to revenue (%): 0
SG&A to revenue (%): 27.378239089777434
Free cash flow (dilution-adjusted): 76651000
Buyback yield (%): 5.526303010707389
Retained earnings: 418353000
Receivables turnover: 9.542580052794674
Capitalized R&D asset: 0
FCF margin (%): 46.095051386441675
Rule of 40 score: 46.095051386441675
Financial ratios for NFBK — annual report dated 2023-12-31
Total revenue: 136563000
Net income: 37669000
Capital expenditures: 3542000
Operating cash flow: 46970000
Depreciation & amortization: 8533000
Net tangible assets: 658433000
Owner earnings: 42660000
Return on net tangible assets (%): 6.4790191257121075
Buffett classification: The Gruesome
Stock price: 11.21
P/E ratio: 12.428595952109163
Shares outstanding: 41763852
Book value: 699445000
P/B ratio: 0.6693489565584142
Market cap (USD): 468172780.92
Debt to equity: 1.195513585771576
Effective tax rate (%): 27.22372488408037
COGS to revenue (%): 0
SG&A to revenue (%): 37.343936498173
Free cash flow (dilution-adjusted): 39000000
Buyback yield (%): 7.940017342945875
Retained earnings: 433227000
Receivables turnover: 7.385376669731221
Capitalized R&D asset: 0
FCF margin (%): 28.558247841655497
Revenue growth (%): -17.876107259049004
Rule of 40 score: 10.682140582606493
Financial ratios for NFBK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.74
Shares outstanding: 41763852
Market cap (USD): 448543770.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NFBK — annual report dated 2024-12-31
Total revenue: 131307000
Net income: 29945000
Capital expenditures: 2637000
Operating cash flow: 31105000
Depreciation & amortization: 8296000
Net tangible assets: 663684000
Owner earnings: 35604000
Return on net tangible assets (%): 5.364601225884607
Buffett classification: The Gruesome
Stock price: 10.87
P/E ratio: 15.16022946201369
Shares outstanding: 41763852
Book value: 704696000
P/B ratio: 0.6442112219169683
Market cap (USD): 453973071.23999995
Debt to equity: 1.0785544404963274
Effective tax rate (%): 26.063553986321324
COGS to revenue (%): 0
SG&A to revenue (%): 40.66424486127929
Free cash flow (dilution-adjusted): 25702000
Buyback yield (%): 4.114120678784956
Retained earnings: 440760000
Receivables turnover: 6.882639689694937
Capitalized R&D asset: 0
FCF margin (%): 19.573975492547998
Revenue growth (%): -3.848773093736957
Rule of 40 score: 15.72520239881104
Financial ratios for NFBK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.87
Shares outstanding: 41763852
Market cap (USD): 453973071.23999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NFBK — quarterly report dated 2025-03-31
Total revenue: 34813000
Net income: 7876000
Capital expenditures: 258000
Operating cash flow: 9426000
Depreciation & amortization: 2003000
Net tangible assets: 670137000
Owner earnings: 9621000
Return on net tangible assets (%): 1.4356765855340026
Buffett classification: The Gruesome
Stock price: 10.32
P/E ratio: 13.680896160487556
Shares outstanding: 41763852
Book value: 711149000
P/B ratio: 0.6060656102167057
Market cap (USD): 431002952.64
Debt to equity: 1.1281559841889675
Effective tax rate (%): 27.047054464616526
COGS to revenue (%): 0
SG&A to revenue (%): 36.31402062447936
Free cash flow (dilution-adjusted): 8108000
Buyback yield (%): 1.2120566617935455
Retained earnings: 443249000
Receivables turnover: 1.7718342833876222
Capitalized R&D asset: 0
FCF margin (%): 23.290150231235458
Rule of 40 score: 23.290150231235458
Financial ratios for NFBK — quarterly report dated 2025-06-30
Total revenue: 38922000
Net income: 9571000
Capital expenditures: 220000
Operating cash flow: 14124000
Depreciation & amortization: 2009000
Net tangible assets: 669262000
Owner earnings: 11360000
Return on net tangible assets (%): 1.6973920527386883
Buffett classification: The Gruesome
Stock price: 10.99
P/E ratio: 26.30737281366424
Shares outstanding: 41763852
Book value: 710274000
P/B ratio: 0.6462079894237999
Market cap (USD): 458984733.48
Debt to equity: 1.3005685129963929
Effective tax rate (%): 30.975046877253714
COGS to revenue (%): 0
SG&A to revenue (%): 37.61368891629412
Free cash flow (dilution-adjusted): 12831000
Buyback yield (%): 2.1787217026109964
Retained earnings: 447524000
Receivables turnover: 2.022867834312146
Capitalized R&D asset: 0
FCF margin (%): 32.965931863727455
Revenue growth (%): 11.803062074512395
Rule of 40 score: 44.76899393823985
Financial ratios for NFBK — quarterly report dated 2025-09-30
Total revenue: 39238000
Net income: 10751000
Capital expenditures: 327000
Operating cash flow: 13921000
Depreciation & amortization: 2009000
Net tangible assets: 678587000
Owner earnings: 12433000
Return on net tangible assets (%): 1.8321895350190913
Buffett classification: The Gruesome
Stock price: 11.43
P/E ratio: 16.928889579402792
Shares outstanding: 41763852
Book value: 719599000
P/B ratio: 0.6633706110764467
Market cap (USD): 477360828.36
Debt to equity: 1.348847066213266
Effective tax rate (%): 27.29424494488402
COGS to revenue (%): 0
SG&A to revenue (%): 36.648147204240786
Free cash flow (dilution-adjusted): 12539000
Buyback yield (%): 0
Retained earnings: 453014000
Receivables turnover: 2.0214311472876205
Capitalized R&D asset: 0
FCF margin (%): 31.956266884142927
Revenue growth (%): 0.8118801705976055
Rule of 40 score: 32.76814705474053
Financial ratios for NFBK — quarterly report dated 2025-12-31
Total revenue: 41343000
Net income: -27402000
Capital expenditures: 345000
Operating cash flow: 16227000
Depreciation & amortization: 1991000
Net tangible assets: 690059000
Owner earnings: -25756000
Return on net tangible assets (%): -3.732434472994338
Buffett classification: The Gruesome
Stock price: 11.22
P/E ratio: 588.6814314572864
Shares outstanding: 41763852
Book value: 690059000
P/B ratio: 0.6790584854918202
Market cap (USD): 468590419.44
Debt to equity: 1.4368684416839719
COGS to revenue (%): 0
SG&A to revenue (%): 32.74314877972087
Free cash flow (dilution-adjusted): 14076000
Buyback yield (%): 0.027102560088995063
Retained earnings: 420404000
Receivables turnover: 2.0550253504324485
Capitalized R&D asset: 0
FCF margin (%): 34.046876133807416
Revenue growth (%): 5.364697487129823
Rule of 40 score: 39.41157362093724
Financial ratios for NFBK — annual report dated 2025-12-31
Total revenue: 154316000
Net income: 796000
Capital expenditures: 1150000
Operating cash flow: 53698000
Depreciation & amortization: 8012000
Net tangible assets: 690059000
Owner earnings: 7658000
Return on net tangible assets (%): 1.1097601799266439
Buffett classification: The Gruesome
Stock price: 11.22
P/E ratio: 588.6814314572864
Shares outstanding: 41763852
Book value: 690059000
P/B ratio: 0.6790584854918202
Market cap (USD): 468590419.44
Debt to equity: 1.4368684416839719
Effective tax rate (%): 95.33165210251599
COGS to revenue (%): 0
SG&A to revenue (%): 35.77010808989346
Free cash flow (dilution-adjusted): 47554000
Buyback yield (%): 3.275995275009159
Retained earnings: 420404000
Receivables turnover: 7.670543791629386
Capitalized R&D asset: 0
FCF margin (%): 30.81598797273128
Revenue growth (%): 17.523056653491437
Rule of 40 score: 48.339044626222716
Financial ratios for NHS — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.04
Shares outstanding: 41855793
Market cap (USD): 294664782.72
Buyback yield (%): 26.392127787424783
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NHS — annual report dated 2022-10-31
Total revenue: -30378739
Net income: -33489406
Capital expenditures: 0
Operating cash flow: -48689899
Net tangible assets: 168278813
Owner earnings: -33489406
Return on net tangible assets (%): -19.901142278677707
Buffett classification: The Gruesome
Stock price: 4.9
Shares outstanding: 41855793
Book value: 168278813
P/B ratio: 1.2187712882191533
Market cap (USD): 205093385.70000002
Debt to equity: 0.272718081271467
Free cash flow (dilution-adjusted): -48689899
Buyback yield (%): 0
Retained earnings: -67686443
Receivables turnover: -4.9274339541541465
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NHS — annual report dated 2023-10-31
Total revenue: 9742007
Net income: 3717522
Capital expenditures: 0
Operating cash flow: -5849107
Net tangible assets: 194428506
Owner earnings: 3717522
Return on net tangible assets (%): 1.912025184208328
Buffett classification: The Gruesome
Stock price: 4.8
P/E ratio: 54.04347476625558
Shares outstanding: 41855793
Book value: 194428506
P/B ratio: 1.0333248479520796
Market cap (USD): 200907806.4
Debt to equity: 0.33945639637841996
COGS to revenue (%): 0
SG&A to revenue (%): 7.205712334224354
Free cash flow (dilution-adjusted): -5849107
Buyback yield (%): 17.918666598910214
Retained earnings: -75991970
Receivables turnover: 1.2312012873639686
Capitalized R&D asset: 0
FCF margin (%): -60.04006156021033
Rule of 40 score: -60.04006156021033
Financial ratios for NHS — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 234140262
Buffett classification: The Gruesome
Stock price: 6.4
Shares outstanding: 41855793
Book value: 234140262
P/B ratio: 1.144088047531099
Market cap (USD): 267877075.20000002
Debt to equity: 0.1857860738192904
Buyback yield (%): 0
Retained earnings: -51921242
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NHS — annual report dated 2024-10-31
Total revenue: 41747733
Net income: 37939889
Capital expenditures: 0
Operating cash flow: 21104961
Net tangible assets: 234140262
Owner earnings: 37939889
Return on net tangible assets (%): 16.203914984941804
Buffett classification: The Gruesome
Stock price: 6.4
P/E ratio: 7.060565601549336
Shares outstanding: 41855793
Book value: 234140262
P/B ratio: 1.144088047531099
Market cap (USD): 267877075.20000002
Debt to equity: 0.1857860738192904
COGS to revenue (%): 0
SG&A to revenue (%): 2.27539301355597
Free cash flow (dilution-adjusted): 21104961
Buyback yield (%): 0
Retained earnings: -51921242
Receivables turnover: 7.2410303045335125
Capitalized R&D asset: 0
FCF margin (%): 50.553549817902685
Revenue growth (%): 328.5331862315434
Rule of 40 score: 379.08673604944613
Financial ratios for NHS — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 227934148
Buffett classification: The Gruesome
Stock price: 6.45
Shares outstanding: 41855793
Book value: 227934148
P/B ratio: 1.1844204443206114
Market cap (USD): 269969864.85
Debt to equity: 0.23471691481699355
Buyback yield (%): 0
Retained earnings: -64965965
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NHS — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 233289950
Buffett classification: The Gruesome
Stock price: 6.77
Shares outstanding: 41855793
Book value: 233289950
P/B ratio: 1.2146417735097461
Market cap (USD): 283363718.60999995
Debt to equity: 0.26147718750850607
Buyback yield (%): 0
Retained earnings: -47126002
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NHS — annual report dated 2025-10-31
Total revenue: 23448066
Net income: 20216092
Capital expenditures: 0
Operating cash flow: 3621527
Net tangible assets: 233289950
Owner earnings: 20216092
Return on net tangible assets (%): 8.66565062061182
Buffett classification: The Gruesome
Stock price: 6.77
P/E ratio: 14.016740654425197
Shares outstanding: 41855793
Book value: 233289950
P/B ratio: 1.2146417735097461
Market cap (USD): 283363718.60999995
Debt to equity: 0.26147718750850607
COGS to revenue (%): 0
SG&A to revenue (%): 3.205048979306012
Free cash flow (dilution-adjusted): 3621527
Buyback yield (%): 0
Retained earnings: -47126002
Receivables turnover: 4.196844857859308
Capitalized R&D asset: 0
FCF margin (%): 15.444885731727299
Revenue growth (%): -43.833917880043934
Rule of 40 score: -28.389032148316637
Financial ratios for NOMD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.79
Shares outstanding: 139791169
Market cap (USD): 3185840741.5099998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOMD — annual report dated 2022-12-31
Total revenue: 3541807228.915663
Gross profit: 982289156.6265061
Operating income: 510963855.42168677
Net income: 300963855.42168677
Capital expenditures: 95301204.81927711
Operating cash flow: 366024096.3855422
Depreciation & amortization: 106746987.95180723
Net tangible assets: -2353012048.1927714
Owner earnings: 312409638.5542169
Return on net tangible assets (%): -13.277009728622632
Capex to operating income (%): 18.65126149493044
Buffett classification: The Great
Stock price: 15.47
P/E ratio: 7.18547873929904
Shares outstanding: 139791169
Book value: 3140000000
P/B ratio: 0.6887163644681529
Market cap (USD): 2162569384.4300003
Debt to equity: 0.8317857416928862
Current ratio: 1.1854804421768708
Quick ratio: 0.6996173469387755
Effective tax rate (%): 22.180685358255452
Interest coverage ratio: 5.134382566585956
COGS to revenue (%): 72.2658774704902
Free cash flow (dilution-adjusted): 260963855.42168674
Buyback yield (%): 1.6546582406904844
Retained earnings: 1068192771.0843374
Inventory turnover: 4.647560708816452
Receivables turnover: 11.018365817091453
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.875141589140809
FCF margin (%): 7.368098785590366
Rule of 40 score: 7.368098785590366
Financial ratios for NOMD — annual report dated 2023-12-31
Total revenue: 3853797468.35443
Gross profit: 1086962025.3164556
Operating income: 522658227.84810126
Net income: 243924050.63291138
Capital expenditures: 104303797.46835442
Operating cash flow: 545316455.6962025
Depreciation & amortization: 120253164.55696201
Net tangible assets: -2507974683.544304
Owner earnings: 259873417.721519
Return on net tangible assets (%): -10.361883611770049
Capex to operating income (%): 19.956405909421164
Buffett classification: The Great
Stock price: 15.21
P/E ratio: 8.716744720223664
Shares outstanding: 139791169
Book value: 3280886075.9493666
P/B ratio: 0.6480638556993327
Market cap (USD): 2126223680.49
Debt to equity: 0.8288514217369499
Current ratio: 1.1333657587548638
Quick ratio: 0.6991245136186771
Effective tax rate (%): 24.01419558359621
Interest coverage ratio: 3.130401819560273
COGS to revenue (%): 71.79504023649203
Free cash flow (dilution-adjusted): 410506329.113924
Buyback yield (%): 10.597025033804396
Retained earnings: 1339240506.329114
Inventory turnover: 4.896505376344085
Receivables turnover: 10.011509371917132
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.662330432200718
FCF margin (%): 10.651995401543768
Revenue growth (%): 8.808786567819062
Rule of 40 score: 19.46078196936283
Financial ratios for NOMD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.54
Shares outstanding: 139791169
Market cap (USD): 2451937104.2599998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOMD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.57
Shares outstanding: 139791169
Market cap (USD): 2176548501.33
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOMD — annual report dated 2024-12-31
Total revenue: 3874750000
Gross profit: 1147250000
Operating income: 570625000
Net income: 283875000
Capital expenditures: 100375000
Operating cash flow: 544250000
Depreciation & amortization: 121125000
Net tangible assets: -2395625000
Owner earnings: 304625000
Return on net tangible assets (%): -12.715888338116358
Capex to operating income (%): 17.59036144578313
Buffett classification: The Great
Stock price: 15.57
P/E ratio: 7.667277855852047
Shares outstanding: 139791169
Book value: 3328125000
P/B ratio: 0.6539864041554929
Market cap (USD): 2176548501.33
Debt to equity: 0.8178028169014084
Current ratio: 1.0984598949523725
Quick ratio: 0.7054215258613015
Effective tax rate (%): 18.27995681899964
Interest coverage ratio: 3.503453568687644
COGS to revenue (%): 70.39163817020453
Free cash flow (dilution-adjusted): 432875000
Buyback yield (%): 7.150081879861806
Retained earnings: 1499375000
Inventory turnover: 4.942242355605889
Receivables turnover: 8.339521119182136
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.599740029764707
FCF margin (%): 11.171688496032003
Revenue growth (%): 0.5436853342092345
Rule of 40 score: 11.715373830241237
Financial ratios for NOMD — quarterly report dated 2025-03-31
Total revenue: 987142857.1428571
Gross profit: 274805194.8051948
Operating income: 118051948.05194806
Net income: 42467532.46753246
Capital expenditures: 24285714.285714284
Operating cash flow: 65714285.71428572
Depreciation & amortization: 31168831.16883117
Net tangible assets: -2549090909.090909
Owner earnings: 49350649.35064934
Return on net tangible assets (%): -1.936009781944161
Capex to operating income (%): 20.57205720572057
Buffett classification: The Great
Stock price: 18.41
P/E ratio: 15.150135125331042
Shares outstanding: 139791169
Book value: 3395194805.194805
P/B ratio: 0.7579993399354703
Market cap (USD): 2573555421.29
Debt to equity: 0.8228971426385648
Current ratio: 1.0620971956105207
Quick ratio: 0.659292806131336
Effective tax rate (%): 17.632241813602015
Interest coverage ratio: 2.553370786516854
COGS to revenue (%): 72.16155768977767
Free cash flow (dilution-adjusted): 36753246.75324675
Buyback yield (%): 2.467655951029053
Retained earnings: 1575324675.3246753
Inventory turnover: 1.185945945945946
Receivables turnover: 1.7943814919735597
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7306044740599713
FCF margin (%): 3.7231943165372976
Rule of 40 score: 3.7231943165372976